B

BridgeBio

Develops therapies for genetic diseases

Associate Director/Director - Business Development & Operations

Corporate StrategyPosted on Nov 10
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • Three to seven years of relevant experience in biopharma business development or strategic planning, management consulting, investment banking, and/or venture capital.
  • Strong scientific acumen, communication skills, and an analytical mindset.
  • Ability to handle multiple projects simultaneously.
  • Proficiency in financial modeling, including revenue forecasting and risk-adjusted net present value (rNPV) models.
  • Tenure-appropriate understanding of the drug development life cycle and operating model.
  • Ability to lead cross-functional teams, drive results, and influence without direct authority.
  • Comfort with ambiguity and a self-starter attitude.
  • Strong written communication and presentation skills.
  • Attention to detail.

Responsibilities

  • Collaborate with functional experts as a strategic partner to support the clinical and commercial success of BBP-418 and the broader BridgeBio Neuromuscular portfolio.
  • Shape the life cycle management strategy for BBP-418, including evaluating new indications, and translate it into actionable milestones and deliverables across cross-functional teams.
  • Conduct scientific, clinical, and commercial assessments to inform portfolio and partnering decisions.
  • Provide strategic and operational input into evidence generation plans that strengthen BBP-418’s value proposition in LGMD2I/R9 and beyond.
  • Synthesize complex data sets into executive-ready insights for senior leadership to drive high-impact decision-making.
  • Present and discuss findings from strategic analyses with the BridgeBio Neuromuscular team, its Executive Team, BridgeBio leadership, and investors.

Desired Qualifications

  • A Ph.D., MD, or other graduate degree in the life sciences is strongly preferred.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs